The 2022 ICD-10 update is effective Oct. 1, 2021
Effective Aug. 18, 2021, the Medicaid and NC Health Choice programs cover anifrolumab-fnia injection
Tobacco-related policy requirements go into effect on July 1, 2022.
Two Months Left to Submit Program Year 2021 Attestations; Security Risk Analysis
Providers are encouraged to confirm which PA types are included in this long-term design.
Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines
Temporary Suspension of Prior Authorization for Post-Acute Placements and Temporary Availability of the Hospital at Home Program
Casirivimab and Imdevimab have been given emergency use authorization for treatment of mild to moderate COVID-19 in some patients.
OSA has begun the Single Audit for state fiscal year 2021
Tips for providers to reduce the likelihood of future documentation errors